.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Merck
McKesson
Federal Trade Commission
Covington
Cipla
Teva
US Army
Novartis

Generated: December 14, 2017

DrugPatentWatch Database Preview

CEFTAZIDIME IN DEXTROSE CONTAINER Drug Profile

« Back to Dashboard

When do Ceftazidime In Dextrose Container patents expire, and when can generic versions of Ceftazidime In Dextrose Container launch?

Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

Summary for CEFTAZIDIME IN DEXTROSE CONTAINER

Drug patent expirations by year for CEFTAZIDIME IN DEXTROSE CONTAINER

Pharmacology for CEFTAZIDIME IN DEXTROSE CONTAINER

Medical Subject Heading (MeSH) Categories for CEFTAZIDIME IN DEXTROSE CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
B BraunCEFTAZIDIME IN DEXTROSE CONTAINERceftazidimeINJECTABLE;INJECTION050823-001Jun 13, 2011RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
B BraunCEFTAZIDIME IN DEXTROSE CONTAINERceftazidimeINJECTABLE;INJECTION050823-002Jun 13, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Dow
Farmers Insurance
Cantor Fitzgerald
Citi
Medtronic
Daiichi Sankyo
Healthtrust
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot